Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Contactin-1 is a novel target antigen in membranous nephropathy associated with chronic inflammatory demyelinating polyneuropathy.
Le Quintrec M, Teisseyre M, Bec N, Delmont E, Szwarc I, Perrochia H, Machet MC, Chauvin A, Mavroudakis N, Taieb G, Lanfranco L, Rigothier C, José B, Concetta C, Geneste C, Pernin V, Larroque C, Devaux J, Beyze A. Le Quintrec M, et al. Among authors: mavroudakis n. Kidney Int. 2021 Dec;100(6):1240-1249. doi: 10.1016/j.kint.2021.08.014. Epub 2021 Oct 1. Kidney Int. 2021. PMID: 34600965
Rituximab Responsive Relapsing-Remitting IgG4 Anticontactin 1 Chronic Inflammatory Demyelinating Polyradiculoneuropathy Associated With Membranous Nephropathy: A Case Description and Brief Review.
Remiche G, Monteiro MLS, Catalano C, Hougardy JM, Delmont E, Boucraut J, Mavroudakis N. Remiche G, et al. Among authors: mavroudakis n. J Clin Neuromuscul Dis. 2022 Jun 1;23(4):219-226. doi: 10.1097/CND.0000000000000395. J Clin Neuromuscul Dis. 2022. PMID: 35608646 Review.
Electrophysiological features of chronic inflammatory demyelinating polyradiculoneuropathy associated with IgG4 antibodies targeting neurofascin 155 or contactin 1 glycoproteins.
Kouton L, Boucraut J, Devaux J, Rajabally YA, Adams D, Antoine JC, Bourdain F, Brodovitch A, Camdessanché JP, Cauquil C, Ciron J, Dubard T, Echaniz-Laguna A, Grapperon AM, Juntas-Morales R, Kremer L, Kuntzer T, Labeyrie C, Lanfranco L, Léger JM, Maisonobe T, Mavroudakis N, Mecharles-Darrigol S, Merle P, Noury JB, Rouaud V, Tard C, Théaudin M, Vallat JM, Viala K, Attarian S, Delmont E. Kouton L, et al. Among authors: mavroudakis n. Clin Neurophysiol. 2020 Apr;131(4):921-927. doi: 10.1016/j.clinph.2020.01.013. Epub 2020 Feb 6. Clin Neurophysiol. 2020. PMID: 32078921
Antibodies against the node of Ranvier: a real-life evaluation of incidence, clinical features and response to treatment based on a prospective analysis of 1500 sera.
Delmont E, Brodovitch A, Kouton L, Allou T, Beltran S, Brisset M, Camdessanché JP, Cauquil C, Cirion J, Dubard T, Echaniz-Laguna A, Grapperon AM, Jauffret J, Juntas-Morales R, Kremer LD, Kuntzer T, Labeyrie C, Lanfranco L, Maisonobe T, Mavroudakis N, Mecharles-Darrigol S, Nicolas G, Noury JB, Perie M, Rajabally YA, Remiche G, Rouaud V, Tard C, Salort-Campana E, Verschueren A, Viala K, Wang A, Attarian S, Boucraut J. Delmont E, et al. Among authors: mavroudakis n. J Neurol. 2020 Dec;267(12):3664-3672. doi: 10.1007/s00415-020-10041-z. Epub 2020 Jul 16. J Neurol. 2020. PMID: 32676765
[The neurology department].
Pandolfo M, Blecic S, Mavroudakis N, Van Bogaert P, Paquier P, Manto M, Zegers de Beyl D. Pandolfo M, et al. Among authors: mavroudakis n. Rev Med Brux. 2002;23 Suppl 2:127-30. Rev Med Brux. 2002. PMID: 12584928 Review. French.
68 results